TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07774455: Pacritinib Effectiveness in Real-world Settings

Sponsor: Swedish Orphan Biovitrum · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 60 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$931,500

Rescue Site Savings

+$621,000

Unlock Full NCT07774455 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07774455 Rescue Dossier →